Oncology Nursing Drug Guide

Oncology Nursing Drug Guide

开发者: Atmosphere Apps, Inc.

中国
APP ID 复制
1350544647
分类
价格
免费
内购
0个评分
医疗(免费)
昨日下载量
最近更新
2020-04-17
最早发布
2018-05-31
版本统计
  • 1706天9小时

    最新版本上线距今

  • 0

    近1年版本更新次数

  • 2018-05-17

    全球最早版本上线日期

版本记录
显示信息
日期
  • 全部
每页显示条数
  • 请选择
  • 版本: 2.0.2.104

    版本更新日期

    2020-04-17

    Oncology Nursing Drug Guide

    Oncology Nursing Drug Guide

    更新日志

    Updated data
    Framework improvements

    视频/截图

    Oncology Nursing Drug Guide App 截图
    Oncology Nursing Drug Guide App 截图
    Oncology Nursing Drug Guide App 截图
    Oncology Nursing Drug Guide App 截图
    Oncology Nursing Drug Guide App 截图

    应用描述

    Written especially for nurses caring for patients with cancer, the Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

    Completely revised and updated, the Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.

    New drugs include:

    apalutamide (Erleada™)
    calaspargase pegol-mknl (Asparlas™)
    Daunorubicin and cytarabine liposome for injection (Vyxeos®)
    glucarpidase (Voraxaze®)
    alpelisib (Piqray®)
    binimetinib (Mektovi®)
    dacomitinib (Vizimpro®)
    Duvelisib (Copiktra®)
    encorafenib (Braftovi®)
    erdafitinib (Balversa™)
    lorlatinib (Lorbrena®)
    anakinra (Kineret®)
    baricitinib (Olumiant®)
    sarilumab (Kevzara®)
    aprepitant injectable emulsion (Cinvanti®)
    granisetron hydrochloride extended-release injection (Sustol®)
    letermovir (Prevymis™)
    omadacycline (Nuzyra™)
    meropenem/vaborbactam (Vabomere™)
    Plazomicin (Zemdri™)
    baloxavir marboxil (Xofluza™)
    imipenem/cilastatin sodium/relebactam (Recarbrio™)
    eravacycline (Xerava™)
    delafloxacin (Baxdela™)

    Subscriptions are $9.99 for one year. Your subscription will auto-renew annually at the end of each year-long term, unless cancelled. Payment will be charged to your iTunes Account at confirmation of purchase. The subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Your account will be charged $9.99 for renewal within 24-hours prior to the end of the current period. Subscriptions may be managed and auto-renewal may be turned off by going to your Account Settings after purchase. No cancellation of the current subscription is allowed during active subscription period. Any unused portion of a free trial period, if offered, will be forfeited when the user purchases a subscription to that publication. Please see the links to our privacy policy and terms of service below.

    Privacy Policy - http://www.jblearning.com/privacy/

    Terms of Use - http://www.jblearning.com/use/

    Print Book - http://www.jblearning.com/catalog/9781284054613/
  • 预订版本: 1.0.3.70

    版本更新日期

    2018-05-17

    预订转上架日期

    2018-05-31
    Oncology Nursing Drug Guide

    Oncology Nursing Drug Guide

    更新日志

    暂无更新日志数据

    应用描述

    暂无应用描述数据